Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

SURPASS: A Randomized, Double-Blind, Multicenter Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus (CMV) Disease in CMV Seropositive Kidney Transplant Recipients (BCV CMV vGCV) (BCV CMV vGCV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02439957
Recruitment Status : Terminated
First Posted : May 12, 2015
Last Update Posted : March 8, 2017
Sponsor:
Information provided by (Responsible Party):
Chimerix

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : May 15, 2016
  Actual Study Completion Date : July 31, 2016